The landscape of wearable technology is shifting from a hardware-centric race to a battle of algorithmic sophistication and ecosystem accessibility. As Samsung prepares the Galaxy Ring 2, the industry is closely watching whether the tech giant can overcome the software hurdles and platform exclusivity that limited its first attempt. Simon Glairy, a distinguished authority in risk management and health-driven technology, joins Benjamin Tailor to dissect the current state of the smart ring market. Their discussion touches on the commoditization of wearable sensors, the strategic necessity of cross-platform compatibility, and the complex trade-offs between one-time purchases and subscription-based health services.
The conversation explores the critical role of continuous software updates in maintaining clinical relevance and the transition from consumer-oriented gadgets to serious health-tech instruments. It also examines how Samsung must adapt its development roadmap to compete with specialized players who prioritize long-term data evolution over annual hardware refreshes.
Given that smart ring hardware is increasingly seen as a commodity, how can a tech giant like Samsung differentiate its next-generation device from established players like Oura?
The reality is that we have reached a point where basic hardware—the collection of optical and motion sensors found in most rings—is a known quantity. When Samsung’s Hon Pak confirmed the development of the Galaxy Ring 2, he essentially acknowledged that the physical shell is just the entry ticket. To truly stand out, Samsung has to pivot away from the hardware arms race and focus on the intelligence behind the glass. This means moving beyond just collecting raw data to offering sophisticated, actionable insights like the ones seen in Oura’s Health Radar or their passive blood pressure tracking. A sleek design is important, but as we saw with the Oura Ring 5 being 40% slimmer, physical refinement only gets you so far if the software isn’t keeping pace. The real differentiator will be the clinical validation and the continuous algorithmic tuning that turns a heart rate reading into a meaningful wellness strategy.
The original Galaxy Ring was heavily criticized for its ecosystem lock-in. How do you see this strategy impacting Samsung’s ability to compete with more open platforms?
Samsung’s decision to gate features like the daily Energy Score and personalized Wellness Tips behind its own devices was a significant strategic misstep. By requiring a Samsung account and a specific smartphone to access Galaxy AI Health Insights, they effectively alienated a massive portion of the potential market. Features like the Double Pinch gestures and the ‘Find My Ring’ tracking tool were essentially locked in a digital walled garden, which doesn’t make sense for a health-focused wearable. Unlike a smartwatch where the operating system needs to talk deeply to the phone’s OS, a smart ring is largely an independent data collector. If Samsung wants to challenge Oura’s dominance, they need to drop the ego and embrace iPhone and non-Samsung Android users. Providing even a basic cross-platform experience would be a monumental shift that could finally allow them to leverage their massive engineering resources on a global scale.
There is a lot of debate regarding the “subscription-free” model versus recurring fees. How does this financial structure dictate the quality of health insights users receive over time?
The tech community often celebrates subscription-free devices, but this “one-and-done” purchase model can actually be a trap for long-term health monitoring. When you look at Oura, their subscription model funds a relentless cadence of updates; in just the last 6 to 12 months, they’ve rolled out Live Activity Tracking, Cumulative Stress metrics, and integrations with third-party blood test reports. This creates a recurring revenue stream that pays for the clinical research and software architecture required to keep the device relevant. Conversely, if a company like Samsung relies solely on the initial sale, they are incentivized to save the best features for the next hardware launch a year or two later. To truly serve a user’s health journey, the software must evolve alongside them, and that requires a business model that supports continuous, high-level development rather than static hardware releases.
Samsung’s leadership has indicated that the second iteration will focus heavily on software and services. What specific changes must the company make to evolve from a consumer electronics brand into a true health-tech leader?
Transitioning from a consumer electronics mindset to a health-tech philosophy requires a fundamental shift in how they view the product lifecycle. Traditional giants tend to tie major software breakthroughs to the launch of a new physical device, but health data doesn’t work on a yearly upgrade cycle. Samsung needs to commit to a software roadmap that provides value long after the initial purchase, moving toward an “ever-improving” experience. This involves investing heavily in clinical validation so that features like their Wellness Tips feel less like generic advice and more like professional-grade guidance. They have the engineering might to lead the field, but they must prioritize user experience and open accessibility over the traditional “user lock-in” tactics that define the smartphone world. If they can treat the ring as a living health instrument rather than just another accessory in their catalog, they will be much more successful in the long run.
If Samsung decides to embrace cross-platform compatibility for the Galaxy Ring 2, how would that shift the power balance in the wearable industry?
Opening the gates to iOS users would be a transformative move that would put Oura on the defensive for the first time in years. Currently, Oura enjoys a significant lead because they provide a premium, specialized experience that doesn’t care which phone you have in your pocket. If Samsung offers a comparable level of insight and hardware quality to the millions of iPhone users, they immediately expand their addressable market by a massive margin. It would force other tech giants to reconsider their own walled gardens and potentially lead to a more standardized, health-first approach across the entire industry. While there is a risk of losing some of the “ecosystem” appeal that keeps people buying Galaxy phones, the potential to dominate the smart ring category—which is still in its relatively early growth stages—is a much bigger prize. It would prove that Samsung is serious about becoming a universal health platform rather than just a hardware vendor.
What is your forecast for the smart ring industry over the next few years?
I expect to see a total convergence where the distinction between a “fitness tracker” and a “clinical tool” becomes almost invisible to the average user. Over the next three years, we will likely see smart rings move beyond basic sleep and heart rate tracking to include sophisticated metabolic monitoring, such as the GLP-1 Insights we are starting to see. The hardware will continue to shrink, perhaps reaching a point where these devices are virtually indistinguishable from traditional jewelry while packing 40% more battery life or sensor density. However, the real winners will be the companies that can manage the “subscription paradox” by providing enough continuous value—through things like blood pressure trends and real-time stress management—to justify a long-term relationship with the user. The market will move away from being a niche accessory for biohackers and become a foundational part of preventative healthcare for the general public.
